The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksODX.L Share News (ODX)

  • There is currently no data for ODX

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AIM WINNERS & LOSERS: Team17 to beat expectations; IOG "disappointed"

Wed, 18th Jan 2023 11:09

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Wednesday.

----------

AIM - WINNERS

----------

Jadestone Energy PLC, up 9.1% at 77.69 pence, 12-month range 5.00p - 110.00p. The Asia Pacific-focused oil and gas company reports that an independent review of its remediation plans and operational readiness for the Montara Venture floating production, storage and offloading unit has been completed and submitted to the National Offshore Petroleum Safety & Environmental Management Authority. Explains this is a major step towards restoring production at Montara. Adds that work required as part of the planned maintenance programme for 2023 is being carried out in parallel with the tank activities, and says production is therefore expected to recommence during February 2023. At the Stag Field, production is expected at 4,000 barrels of oil per day once planned overwork activity is completed.

----------

Team17 Group PLC, up 8.1% at 445.75 pence, 12-month range 335.00p - 810.00p.The video game and educational entertainment app publisher and developer reports strong trading in the second half of 2022, with multiple new first and third-party games released. Also notes extended games distribution to "wider platforms" and "strong support" across its portfolios with additional new content updates. As a result, expects full-year revenue and adjusted earnings before interest, tax, depreciation and amortisation to be significantly ahead of market expectations, which it does not specify.

----------

AIM - LOSERS

----------

IOG PLC, down 53% at 7.80 pence, 12-month range 7.10p - 46.00p. The North Sea-focused gas and infrastructure operator says that the clean-up phase for Southwark A2 has taken longer than planned following a hydraulic stimulation phase. Gas rates from A2, to-date, has also been lower than expected, with a maximum stabilised rate of 4.2 million standard cubic feet per day via coiled tubing, at a flowing wellhead pressure of 456 pounds per square inch. Chief Operating Officer Dougie Scott says the low gas rate and apparent formation water production at this stage of the A2 well clean-up is "unexpected and disappointing".

----------

Omega Diagnostics Group PLC, down 11% at 3.42 pence, 12-month range 2.12p - 16.97p. The medical diagnostics firm expects lower-than-expected revenue and significant back-end phasing of orders in financial 2023, but a stronger opening order book for financial 2024. Notes "several headwinds" impacting its ability to fulfil orders ahead of year-end on March 31. Says its current order book is GBP2.5 million, and further orders are expected, but says a number of orders will move into financial 2024. Full-year revenue from the Health & Nutrition business is now expected between GBP7.5 million to GBP8.0 million for the year ended March 31. This will result in loss before interest, tax, depreciation and amortisation from continuing operations of around GBP1.0 million, Omega explains.

----------

By Heather Rydings, Alliance News senior economics reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
23 Jun 2014 10:10

UK WINNERS & LOSERS: Mining Companies Cheered By China PMI Data

Read more
23 Jun 2014 09:58

Omega Diagnostic Profit Up, Optimistic As It Ramps Up Visitect CD4 Commercialisation

Read more
23 Jun 2014 07:37

Omega Diagnostics' full-year results meet targets

- Adjusted pre-tax profit surges 41% - Strong performance from food intolerance division - Positive about future prospects Medical diagnostics company Omega reported a surge in full-year adjusted pre-tax profit after a robust performance from its food intolerance division and said it remains positi

Read more
14 Apr 2014 07:23

Omega Diagnostics Set To Meet Full Year Expectations

LONDON (Alliance News) - Omega Diagnostics Group PLC Monday said it had met market expectations for its last financial year, with revenues and adjusted pretax profit ahead of the previous year. The medical diagnostics company expects to post revenues of GBP11.6 million in the year to end-Ma

Read more
14 Apr 2014 07:15

UK MORNING BRIEFING: Glencore Sells Interest In Peru Copper Project

LONDON (Alliance News) - Glencore Xstrata said Monday it has agreed to sell its interest in the Las Bambas copper project in Peru to a Chinese consortium including MMG, Guoxin International Investment Corp and CITIC Metal Co for USD5.85 billion in cash. The deal is part of an agreement to w

Read more
24 Mar 2014 16:40

DIRECTOR DEALINGS: Omega Diagnostics Finance Director Buys Shares

LONDON (Alliance News) - Omega Diagnostics Group PLC said Monday that Finance Director Kieron Harbinson had bought 40,000 shares at 28.5 pence each. Following this transaction Harbinson's total share in the medical diagnostics products company is 0.33%. Shares in Omega closed down 0.9

Read more
5 Mar 2014 14:49

DIRECTOR DEALINGS: Omega Diagnostics Executives Buy Shares

LONDON (Alliance News) - Omega Diagnostics Group PLC Wednesday said Chief Executive Andrew Shepherd bought 18,000 shares at a price of 29.935 pence per share. Following this transaction, Shepperd holds 2.7 million shares, which represents a 2.46% stake in the firm. The company also sa

Read more
25 Feb 2014 11:11

Omega Diagnostics Gets Backdated Patent For CD4 Tests In 15 African States

LONDON (Alliance News) - Omega Diagnostics Group PLC said Tuesday that it had received a backdated patent for its CD4 test in 15 of the African Regional International Property Organisation States. The patent is valid from July 24, 2013. Omega produces Visitect CD4, a disposable, semi-

Read more
24 Feb 2014 13:50

UK MIDDAY BRIEFING: RSA Insurance, HSBC Lead FTSE 100 Lower

LONDON (Alliance News) - RSA Insurance is leading the FTSE 100 lower Monday after the struggling insurer confirmed it is considering a number of measures to bolster its balance sheet, while HSBC Holdings is also down after its results missed market forecasts.<

Read more
24 Feb 2014 11:42

UK WINNERS & LOSERS: Dixons, Carphone Warehouse Rise On Merger Talks

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices midday Monday.

-------

FTSE 100 - WINNERS

Vodafone Group, up 6%. Vodafone's shares have jumped after the 6-for-11 consolidation of i

Read more
24 Feb 2014 09:57

Omega Diagnostics Shares Up On Grant, IDs-iSYS Project Progress

LONDON (Alliance News) - Shares in Omega Diagnostics Group PLC rose Monday after it announced that it had been granted a USD600,000 grant from Burnet Institute Melbourne and global health initiative UNITAID to build an assembly facility in India for its Visitect CD4 test. Shares in Omega we

Read more
24 Feb 2014 08:30

UK MORNING BRIEFING: HSBC Shares Fall On Lower-Than-Expected Profit

LONDON (Alliance News) - Shares have opened lower Monday amid a raft of UK corporate announcements. HSBC Holdings is the biggest faller in the FTSE 100, down 4.0%, as it reported just after the open lower-than-expected pretax profit in its recent full year.

Here is

Read more
13 Feb 2014 14:11

UK MIDDAY BRIEFING: Rolls-Royce, Tate & Lyle Weigh On FTSE 100

LONDON (Alliance News) - London's equity markets have focused on individual stocks Thursday after a plethora of earnings reports and trading updates, with Rolls-Royce Holdings and Tate & Lyle among the biggest losers after they cut guidance, and Im

Read more
13 Feb 2014 11:54

UK WINNERS & LOSERS: Tate & Lyle And Rolls Royce Guidance Disappoints

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices midday Thursday.

-------

FTSE 100 - WINNERS

Imperial Tobacco Group, up 3.4%. The company has maintained its expecta

Read more
13 Feb 2014 11:20

Omega Diagnostics makes progress with HIV blood test

Shares in Omega Diagnostics rose after the medical group said it had passed a major milestone in developing its Visitect CD4 HIV blood test. The stock lifted 2.75p, or more than 16%, to 19.5p by 11:44 in London as Omega said it had completed the technology transfer phase for Visitect CD4, which ens

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account